Ding, Xiaoyan, et al. “Patients With UHCC and Child-Pugh B8 9 Also Benefit from a Combination of Antiangiogenic Agents and PD-1 Inhibitors: A Multicenter Real-World Study”. Acta Oncologica, vol. 64, May 2025, pp. 607-15, doi:10.2340/1651-226X.2025.42652.